SEARCH

SEARCH BY CITATION

References

  • 1
    Colombo M. The natural history of hepatitis C. In: Alberti A, ed. Bailliere's Clinical Gastroenterology. 1996: 275288.
  • 2
    Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, et al. Recombinant interferon alpha therapy for chronic hepatitis C: a randomized double blind placebo-controlled trial. N Engl J Med 1989; 321: 15061510.
  • 3
    Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, et al. Treatment of chronic hepatitis C with recombinant interferon alpha. New Engl J Med 1989; 321: 15011506.
  • 4
    Poynard T, Leroy V, Cohard M, Theneust T, Mathurina P, Opolon P, Zarski JP. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996; 24: 778789.
  • 5
    Chemello L, Bonetti P, Cavalletto L, Taloto T, Donadon V, Casause P, Belum F, et al. Randomized trial comparing three different regimens of alpha 2a interferon in chronic hepatitis C. Hepatology 1995; 22: 700706.
  • 6
    Marriott E, Quiroga JA, Carreno V. Retreatment of chronic hepatitis C with interferon-alpha. J Infect Diseases 1992; 166: 12001201.
  • 7
    Pardo M, Cotonat T, Herrero M, Marriott E, Artillo S, Quiroga JA, Carreno V. Retreatment of chronic hepatitis C virus infection. Lancet 1994; 343: 15681569.
  • 8
    Castillo I, Bartolomè J, Navas S, Gonzales S, Herrero H, Carreño V. Virological and biochemical long term follow-up of patients with chronic hepatitis C treated with interferon. Hepatology 1994; 19: 13421346.
  • 9
    Marcellin P, Boyer N, Pouteau M, Benhamou JP, Erlinger S. Retreatment with interferon-alpha of chronic hepatitis C virus infection. Lancet 1994; 344: 690691.
  • 10
    Gordon SC, Everson G, McHutchinson JG, Reinus J, Regenstein F, Kaplan MM, Koff RS, et al. Natural alfa interferon treatment of chronic hepatitis C in patients refractory to recombinant interferon alfa 2b [Abstract]. Hepatology 1995; 22: 117A.
  • 11
    Horiike N, Kurose K, Ohkura I, Masumoto T, Nakanishi K, Michitaka K, Onji M. Retreatment with interferon in chronic hepatitis C [Abstract]. J Hepatol 1994; 21: 1155.
  • 12
    Van Thiel DH, Friedlander L, Molloy PJ, Kania RJ, Fagiuoli S, Wright HI, Gasbarrini A, et al. Retreatment of hepatitis C interferon with and without phlebotomy. Hepatol Gastroenterol 1996; 43: 15571561.
  • 13
    Ciprani A Giudici, Ponassi I, Varagona G, Marenco G, Grasso A, Menardo G, De Conca V, et al. Retreatment of patients with chronic hepatitis C non-responder to a first interferon course: analysis of a large patient cohort [Abstract]. Hepatology 1996; 24: 273A.
  • 14
    Puoti M, Castelnuovo F, Rossi S, Spinetti A, Forleo MA, El Hamad I, Zaltron A, et al. Retreatment of patients with chronic hepatitis C (CHC) without primary response to interferon-alpha is ineffective, (in press)
  • 15
    Iaquinto G, Ambrosone L, De Vita A, Masucci F, Rambaldi A, Rambaldi M. Response to retreatment with alfa interferon in relapsed and non responder patients [Abstract]. J Hepatol 1995; 23 (suppl 1): 194.
  • 16
    Rolachon A, Kezachian G, Causse X, Baud M, Fournet J, Zarski JP. Interest of higher dose of interferon alpha in non-responder patients with chronic hepatitis C: a prospective randomized study [Abstract]. Hepatology 1196; 24: 560A.
  • 17
    Bonkovsky HL, Clifford BD, Smith LJ, Allan C, Banner B. High-dose interferon-alpha-2b for retreatment of non-responders or relapsing patients with chronic hepatitis C: a controlled randomized trial. Dig Dis Sci 1996; 41: 149154.
  • 18
    Chemello L, Cavalletto L, Donada C, Bonetti P, Casarin P, Urban F, Pontisso P, et al. Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C. (submitted)
  • 19
    Payen JL, Izopeet J, Galindo V, Zarski JP, Seigneurin JM, Dussaix E, Langlois C, et al. Comparison of three interferon alfa-2b regimens for retreatment (RTT) of patients with chronic hepatitis C with prior complete response followed by relapse: a controlled randomized trial [Abstract]. Hepatology 1996; 24: 273A.
  • 20
    Chow WC, Marcellin P, Boyer N, Pouteau M, Castelnau C, Degos F, Maghinici C, et al. Interferon retreatment in chronic hepatitis C patients after a standard course of interferon therapy [Abstract]. Hepatology 1996; 24: 274A.
  • 21
    Picciotto A, Brizzolara R, Campo N, Poggi G, Sinelli N, De Conca V, Cipriani A Giudici, et al. Two year interferon retreatment may induce a sustained response in relapsing patients with chronic hepatitis C [Abstract]. Hepatology 1996; 24: 273A.
  • 22
    Le X, Zhou X, Dai X. Evaluation of interferon alpha for the treatment of relapsed hepatitis C [Abstract]. Hepatology 1996; 24: 536A.
  • 23
    Weiland O, Zhang YY, Widell A. Serum HCV-RNA levels in patients with chronic hepatitis C given a second course of interferon alpha 2b treatment after relapse following initial treatment. Scand J Infect Dis 1993; 25: 2530.
  • 24
    Craxi A, Almasio P, Fuschi P, Di Marco V, Camus C, Bunura C, Lo laconic O, et al. Should patients with chronic hepatitis C who relapse after interferon be retreated [Abstract]? J Hepatol 1997; 26: 192.
  • 25
    Toyoda H, Nakano S, Takeda I, Kumada T, Sugiyama K, Osada T, Kiriyama S, et al. Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol 1994; 89: 14531457.
  • 26
    Arase Y, Kumada H, Chayama K, Tsubota A, Koida I, Ikeda K, Saitoh S, et al. Interferon retreatment of non-responders with HCV-RNA positive chronic hepatitis C. J Gastroenterol 1994; 29: 299304.